EWS & EVENTS
Agonist Redirected Checkpoint Platform (ARC); Engineering Bi-Functional Fusion Proteins (SIRPα-Fc-CD40L), for Cancer Immunotherapy

SITC 2018

2018_SITC_k_SIRPa
MIGHT ALSO LIKE
YOU MIGHT ALSO LIKE
Agonist Redirected Checkpoint Platform (ARC); Engineering Bi-Functional Fusion Proteins (PD1-Fc-OX40L), for Cancer Immunotherapy

SITC 2018

Read more
Takeda and Shattuck Labs Announce Collaboration to Explore ARC Fusion Proteins in Immuno-Oncology

Press Release 2017

Read more